Why the study?
Does the integration of artificial intelligence, digital twin technology, and 3D printing improve diagnosis, risk assessment, and personalized treatment in patients with valvular heart disease?
Does the integration of artificial intelligence, digital twin technology, and 3D printing improve diagnosis, risk assessment, and personalized treatment in patients with valvular heart disease?
The integration of artificial intelligence, digital twin technology, and 3D printing offers transformative potential to enhance diagnostic precision, risk stratification, and personalized treatment planning in valvular heart disease.
Answers are grounded in this paper and cite their sources.
Surveys AI applications in valvular heart disease; leaves open prospective validation before clinical adoption.
Article Current applications and future perspectives of artificial intelligence in valvular heart disease was published on February 1, 2025 in the journal Journal of Translational Internal Medicine (volume 13, issue 1).
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: